Parameters | Group-1 (n = 156) | Group-2 (n = 60) | Group-3 (n = 122) | Group-4 (n = 41) | Total (n = 379) | Test Statistics | |
---|---|---|---|---|---|---|---|
Demographic data and comorbidities | Age (years) | 52.2 ± 12.6 | 51.9 ± 13.3 | 50.9 ± 14.5 | 50.8 ± 12.8 | 51.6 ± 13.3 | p:0.981 * |
Female | 117 (75.0%) | 44 (73.3%) | 79 (64.8%) | 24 (58.5%) | 264 (69.7%) | p:0.099** | |
HT | 63 (40.4%) | 26 (43.3%) | 58 (47.5%) | 22 (53.7%) | 169 (44.6%) | p:0.399** | |
DM | 48 (30.8%) | 18 (30.0%) | 26 (21.3%) | 13 (31.7%) | 105 (27.7%) | p:0.295** | |
COPD | 15 (9.6%) | 8 (13.3%) | 12 (9.8%) | 4 (9.8%) | 39 (10.3%) | p:0.869** | |
CRF | 3 (1.9%) | 1 (1.7%) | 2 (1.6%) | 0 (0.0%) | 6 (1.6%) | p:0.854** | |
AF | 102 (65.4%) | 48 (80.0%) | 55 (45.1%) | 18 (43.9%) | 223 (58.8%) | p:0.001** | |
CVE | 3 (1.9%) | 6 (10.0%) | 2 (1.6%) | 4 (9.8%) | 15 (4.0%) | p:0.005** | |
Previous operations | CMC | 6 (3.8%) | 3 (5.0%) | 3 (2.5%) | 0 (0.0%) | 12 (3.2%) | p:0.381 ** |
MVR | 4 (2.6%) | 2 (3.3%) | 3 (2.5%) | 0 (0.0%) | 9 (2.4%) | ||
AVR | 2 (1.3%) | 0 (0.0%) | 0 (0.0%) | 1 (2.4%) | 3 (0.8%) | ||
ASD | 0 (0.0%) | 1 (1.7%) | 0 (0.0%) | 1 (2.4%) | 2 (0.5%) | ||
ECHO measurements | EF % | 52.8 ± 8.7 | 51.6 ± 9.8 | 51.6 ± 9.5 | 52.3 ± 7.5 | 52.2 ± 9.0 | p:0.803 * |
SPAP | 50.8 ± 11.5 | 52.0 ± 12.7 | 49.5 ± 7.8 | 54.7 ± 12.4 | 51.0 ± 10.9 | p:0.148 * | |
FTR Degree | 2 | 49 (31.4%) | 19 (15.6%) | 45 (36.9%) | 9 (7.4%) | 122 (32.2%) | p:0.508** |
3 | 100 (42.2%) | 39 (16.5%) | 70 (29.5%) | 28 (11.8%) | 237 (62.5%) | ||
4 | 7 (4.5%) | 2 (3.3%) | 7 (5.7%) | 4 (9.7%) | 20 (5.3%) | ||
Mean ± Std. D. | 2.7 ± 0.5 | 2.7 ± 0.5 | 2.7 ± 0.6 | 2.9 ± 0.5 | 2.7 ± 0.5 | p:0.303 * | |
Mitral Valve Structure | NON-Mitral Valve | 0 (0.0%) | 0 (0.0%) | 14 (11.5%) | 12 (29.3%) | 26 (6.9%) | p:0.001 ** |
MVI | 32 (20.5%) | 11 (11.6%) | 37 (30.3%) | 15 (15.8%) | 95 (25.1%) | ||
MVS | 124 (48.1%) | 49 (19.0%) | 71 (27.5%) | 14 (5.4%) | 258 (68.1%) | ||
Functional NHYA Class | 2 | 23 (14.7%) | 12 (16.9%) | 31 (25.4%) | 5 (7.0%) | 71 (18.7%) | p:0.001 ** |
3 | 112 (43.1%) | 42 (16.2%) | 84 (32.3%) | 22 (8.5%) | 260 (68.6%) | ||
4 | 21 (13.5%) | 6 (10.0%) | 7 (5.7%) | 14 (29.2%) | 48 (12.7%) | ||
Mean ± Std. D. | 3.0 ± 0.5 | 2.9 ± 0.5 | 2.8 ± 0.5 | 3.2 ± 0.6 | 2.9 ± 0.5 | p:0.001 * |